These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

414 related items for PubMed ID: 22670381

  • 1. [Generic drugs: we must cut pharmaceutical spending but undertaking drug quality].
    Carrillo Norte JA, Postigo Mota S.
    Rev Enferm; 2012 Feb; 35(2):10-9. PubMed ID: 22670381
    [Abstract] [Full Text] [Related]

  • 2. The generics in transplantation and the rules on their use.
    Masri M.
    Exp Clin Transplant; 2003 Jun; 1(1):65-8. PubMed ID: 15859910
    [Abstract] [Full Text] [Related]

  • 3. Quantitative assessment of the switchability of generic products.
    Karalis V, Bialer M, Macheras P.
    Eur J Pharm Sci; 2013 Nov 20; 50(3-4):476-83. PubMed ID: 23981332
    [Abstract] [Full Text] [Related]

  • 4. Potential concerns about generic substitution: bioequivalence versus therapeutic equivalence of different amlodipine salt forms.
    Meredith PA.
    Curr Med Res Opin; 2009 Sep 20; 25(9):2179-89. PubMed ID: 19601710
    [Abstract] [Full Text] [Related]

  • 5. [Generic drug substitution].
    Tamir O, Halkin H, Shemer J.
    Harefuah; 2006 Sep 20; 145(9):691-5, 701. PubMed ID: 17078434
    [Abstract] [Full Text] [Related]

  • 6. Generic products of antiepileptic drugs (AEDs): is it an issue?
    Bialer M.
    Epilepsia; 2007 Oct 20; 48(10):1825-32. PubMed ID: 17850324
    [Abstract] [Full Text] [Related]

  • 7. Generics: keep a balanced view.
    Prescrire Int; 2014 Feb 20; 23(146):52-5. PubMed ID: 24669392
    [Abstract] [Full Text] [Related]

  • 8. Comparing generic and innovator drugs: a review of 12 years of bioequivalence data from the United States Food and Drug Administration.
    Davit BM, Nwakama PE, Buehler GJ, Conner DP, Haidar SH, Patel DT, Yang Y, Yu LX, Woodcock J.
    Ann Pharmacother; 2009 Oct 20; 43(10):1583-97. PubMed ID: 19776300
    [Abstract] [Full Text] [Related]

  • 9. What makes a generic medication generic?
    Howland RH.
    J Psychosoc Nurs Ment Health Serv; 2009 Dec 20; 47(12):17-20. PubMed ID: 20000278
    [Abstract] [Full Text] [Related]

  • 10. [The clinical and economic impact of generic drugs in the treatment of epilepsy].
    Argumosa A, Herranz JL.
    Rev Neurol; 2009 Dec 20; 41(1):45-9. PubMed ID: 15999330
    [Abstract] [Full Text] [Related]

  • 11. Medicare Spending on Brand-name Combination Medications vs Their Generic Constituents.
    Sacks CA, Lee CC, Kesselheim AS, Avorn J.
    JAMA; 2018 Aug 21; 320(7):650-656. PubMed ID: 30140875
    [Abstract] [Full Text] [Related]

  • 12. Product individuality of commercially available low-molecular-weight heparins and their generic versions: therapeutic implications.
    Maddineni J, Walenga JM, Jeske WP, Hoppensteadt DA, Fareed J, Wahi R, Bick RL.
    Clin Appl Thromb Hemost; 2006 Jul 21; 12(3):267-76. PubMed ID: 16959680
    [Abstract] [Full Text] [Related]

  • 13. [Generic drugs].
    Delporte JP.
    Rev Med Liege; 2002 Jan 21; 57(1):13-22. PubMed ID: 11899492
    [Abstract] [Full Text] [Related]

  • 14. [Bioequivalence and generics of index drugs with narrow therapeutic margins].
    Le Corre P.
    Presse Med; 2010 Feb 21; 39(2):169-76. PubMed ID: 19932591
    [Abstract] [Full Text] [Related]

  • 15. Loss of response after switching from brand name to generic formulations: three cases and a discussion of key clinical considerations when switching.
    Margolese HC, Wolf Y, Desmarais JE, Beauclair L.
    Int Clin Psychopharmacol; 2010 May 21; 25(3):180-2. PubMed ID: 20216221
    [Abstract] [Full Text] [Related]

  • 16. [Generic drugs in psychopharmacology: pros and cons].
    Cuenca E, Zaragozá F.
    Actas Esp Psiquiatr; 1999 May 21; 27(6):351-7. PubMed ID: 10611558
    [Abstract] [Full Text] [Related]

  • 17. Current regulatory approaches of bioequivalence testing.
    Karalis V, Macheras P.
    Expert Opin Drug Metab Toxicol; 2012 Aug 21; 8(8):929-42. PubMed ID: 22681436
    [Abstract] [Full Text] [Related]

  • 18. Evaluation of clinical and safety outcomes associated with conversion from brand-name to generic tacrolimus in transplant recipients enrolled in an integrated health care system.
    Spence MM, Nguyen LM, Hui RL, Chan J.
    Pharmacotherapy; 2012 Nov 21; 32(11):981-7. PubMed ID: 23074134
    [Abstract] [Full Text] [Related]

  • 19. The bioequivalence and therapeutic efficacy of generic versus brand-name psychoactive drugs.
    Borgheini G.
    Clin Ther; 2003 Jun 21; 25(6):1578-92. PubMed ID: 12860486
    [Abstract] [Full Text] [Related]

  • 20. Generic drugs in dermatology: part II.
    Payette M, Grant-Kels JM.
    J Am Acad Dermatol; 2012 Mar 21; 66(3):353.e1-15; quiz 367-8. PubMed ID: 22342022
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.